Arkolith/Insider Trading/MGRX/Form 4

Cohen Jacob D.

Chief Executive Officer, Director, 10% OwnerMANGOCEUTICALS, INC. (MGRX) · full profile →Form 4 · filed Mar 20, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 9, 2025Grant(A)500K—$0500K
Jun 5, 2025Gift(G)200K—$00
Jun 5, 2025Gift(G)200K—$0805K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 9, 2025Grant(A)0—$0—
Jul 21, 2025Grant(A)50K——50K
Jul 21, 2025Grant(A)2.0M——2.0M

Transaction Codes

A
Grant / award
G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-26-011921) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML